Final rule 2026-15074
Medical Devices; Gastroenterology-Urology Devices; Classification of the Non-Medicated Topical Formulation for Treatment of Erectile Dysfunction
The Food and Drug Administration (FDA) is classifying the non- medicated topical formulation for treatment of erectile dysfunction into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the non-medicated topical formulation for treatment of erectile dysfunction. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-15074
- Published
- Jul 27, 2026
- Effective
- Jul 27, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 46833
Docket identifiers
- Docket No. FDA-2026-N-7628
CFR references
- Title 21, part 876